A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma. | LitMetric

AI Article Synopsis

  • Ewing Sarcoma (ES) is a highly aggressive cancer with a low 5-year overall survival rate of less than 30% in advanced stages, linked to specific chromosomal translocations that influence its development.
  • Genomic profiling of tumors from 189 ES patients revealed that single nucleotide variants (SNVs) were found in 51% of cases, with common alterations affecting various signaling pathways and the fibroblast growth factor receptor contributing to cancer progression.
  • The study highlights the presence of mutations and pathway alterations in ES, providing new insights into its complex genetic landscape and potential targets for therapy.

Article Abstract

Ewing Sarcoma (ES) is an aggressive, mesenchymal malignancy associated with a poor prognosis in the recurrent or metastatic setting with an estimated overall survival (OS) of <30% at 5 years. ES is characterized by a balanced, reciprocal chromosomal translocation involving the RNA-binding protein and transcription factor gene ( being the most common). Interestingly, murine ES models have failed to produce tumors phenotypically representative of ES. Genomic alterations (GA) in ES are infrequent and may work synergistically with translocations to promote oncogenesis. Aberrations in fibroblast growth factor receptor (), a receptor tyrosine kinase (RTK) have been shown to contribute to carcinogenesis. Mouse embryonic fibroblasts (MEFs) derived from knock-in strain of homologous mice display a transformed phenotype with enhanced TGF-induced mammary carcinogenesis. The association between the SNV in high-grade soft tissue sarcomas has previously been demonstrated conferring a statistically significant association with poorer OS. How the SNV specifically relates to ES has not previously been delineated. To further define the genomic landscape and corresponding pathway alterations in ES, comprehensive genomic profiling (CGP) was performed on the tumors of 189 ES patients. The SNV was identified in a significant proportion of the evaluable cases ( = 97, 51%). In line with previous analyses, ( = 36, 19%), ( = 33, 17%), and ( = 22, 11.6%) represented the most frequent alterations in our cohort. Co-occurrence of and alterations was observed ( = 5, 3%). Notably, we identified a higher proportion of mutations than previously observed. The most frequent pathway alterations affected ( = 89, 24% of pathological samples), ( = 75, 25%), ( = 69, 23%), Histone/Chromatin remodeling ( = 57, 24%), and ( = 64, 20%). These findings help to further elucidate the genomic landscape of ES with a novel investigation of the SNV revealing frequent aberration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608227PMC
http://dx.doi.org/10.3390/jpm13101499DOI Listing

Publication Analysis

Top Keywords

ewing sarcoma
8
bioinformatic analysis
4
analysis recurrent
4
recurrent genomic
4
genomic alterations
4
alterations corresponding
4
corresponding pathway
4
pathway alterations
4
alterations ewing
4
sarcoma ewing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!